Characteristics of Benign Prostatic Hyperplasia (BPH) Patients Undergoing Transurethral Resection of the Prostate (TURP)
DOI:
https://doi.org/10.21776/ub.jkb.2021.031.04.4Keywords:
Benign Prostatic Hyperplasia, recurrent urinary retention, Transurethral Resection of the ProstateAbstract
Benign prostatic hyperplasia (BPH) is one of the most common diseases affecting the elderly, and Transurethral Resection of the Prostate (TURP) is a gold standard surgical procedure in BPH patients. Although the TURP rate is high, the publication of TURP profile data in Indonesia is still limited. This study aimed at determining the characteristics of BPH patients who underwent TURP at Saiful Anwar General Hospital. This study is a descriptive study by collecting data of 162 BPH patients who underwent TURP from January 2015 to August 2017. TURP is primarily performed in patients aged 61-70 years (39.5%). Recurrent urinary retention was the most common indication for the procedure (54.9%) followed by bladder stone (21%), pharmacological therapy failure (10.5%), inguinal hernia (8%), severe Lower Urinary Tract Symptoms (LUTS) (3.7%), and renal insufficiency (1.9%). As many as 58% of patients who underwent TURP had a prostate volume higher than 50 ml. Urinary retention is the most common complaint among BPH patients who underwent TURP, and recurrent urinary retention is the most common TURP indicator.Â
Downloads
References
Wei JT, Calhoun E, and Jacobsen SJ. Urologic Diseases in America Project: Benign Prostatic Hyperplasia. The Journal of Urology. 2005; 173(4): 1256–1261.
Adelia F, Monoarfa A, and Wagiu A. Gambaran Benigna Prostat Hiperplasia di RSUP Prof. Dr. R. D. Kandou Manado Periode Januari 2014 – Juli 2017. Jurnal e-Clinic. 2017; 5(2): 250-252.
Lim KB. Epidemiology of Clinical Benign Prostatic Hyperplasia. Asian Journal of Urology. 2017; 4(3): 148–151.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, and Jemal A. Global Cancer Statistics 2018: GLOBOCAN Estimates Of Incidence And Mortality Worldwide For 36 Cancers In 185 Countries. CA: A Cancer Journal for Clinicians. 2018; 68(6): 394–424.
Lokeshwar SD, Harper BT, Webb E, et al. Epidemiology and Treatment Modalities for the Management of Benign Prostatic Hyperplasia. Translational Andrology and Urology. 2019; 8(5): 529–539.
Rosette JJD, Alivizatos G, Madersbacher S, et al. Guidelines on Benign Prostatic Hyperplasia (BPH). European Urology. 2001; 40(3): 256–263.
Kapoor A. Benign Prostatic Hyperplasia (BPH) Management in the Primary Care Setting. The Canadian Journal of Urology. 2012; 19(1): 10–17.
Tjahjodjati. Panduan Penatalaksanaan Klinis Pembesaran Prostat Jinak (Benign Prostatic Hyperplasia/BPH). Edisi 3. Jakarta: Ikatan Ahli Urologi Indonesia; 2017.
Hiort O, Birnbaum W, Marshall L, et al. Management of Disorders of Sex Development. Nature Reviews. Endocrinology. 2014; 10(9): 520–529.
Kim EH, Larson JA, and Andriole GL. Management of Benign Prostatic Hyperplasia. Annual Review of Medicine. 2016; 67: 137–151.
Daryanto B, Ali M, Purnomo BB, and Mintaroem K. Upregulation of Alpha-1 Receptor Gene Expression in Benign Prostate Hyperplasia Patients Receiving Long-Term Alpha-Blocker Therapy. Drug Inventory Today. 2019; 12(4): 657–662.
Budaya TN and Daryanto B. A to Z BPH (Benign Prostatic Hyperplasia). Malang, Jawa Timur: UB Press; 2019; p. 138.
Ingimarsson JP, Isaksson HJ, Sigbjarnarson HP, Gudmundsson J, and Geirsson G. Increased Population Use of Medications for Male Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Correlates with Changes in Indications for Transurethral Resection of the Prostate. Scandinavian Journal of Urology. 2014; 48(1): 73–78.
Macey MR and Raynor MC. Medical and Surgical Treatment Modalities for Lower Urinary Tract Symptoms in the Male Patient Secondary to Benign Prostatic Hyperplasia: A Review. Seminars in Interventional Radiology. 2016; 33(3): 217–223.
Rajeev R, Giri B, Choudhary LP, and Kumar R. Surgery for Benign Prostatic Hyperplasia: Profile of Patients in a Tertiary Care Institution. The National Medical Journal of India. 2017; 30(1): 7–10.
Agrawal M, Kumar M, Pandey S, Aggarwal A, and Sankhwar S. Changing Profiles of Patients Undergoing Transurethral Resection of the Prostate Over a Decade: A Single-Center Experience. Urology Annals. 2019; 11(3): 270–275.
Persu C, Georgescu D, Arabagiu I, Cauni V, Moldoveanu C, and Geavlete P. TURP for BPH. How Large is Too Large? Journal of Medicine and Life. 2010; 3(4): 376–380.
Mayer EK, Kroeze SGC, Chopra S, Bottle A, and Patel A. Examining the “Gold Standardâ€: A Comparative Critical Analysis of Three Consecutive Decades of Monopolar Transurethral Resection of the Prostate (TURP) Outcomes. BJU International. 2012; 110(11): 1595–1601.
Negro CLA and Muir GH. Chronic Urinary Retention in Men: How We Define It, and How Does it Affect Treatment Outcome. BJU International. 2012; 110(11): 1590–1594.
Fan YH, Chung HJ, Huang E, Lin A, and Chen KK. Mp3-10 Reduction of Enlarged Prostate Decreases the Incidence of Inguinal Hernia. The Journal of Urology. 2015; 193(4S): e22.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
